News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Lannett Company, Inc. Announces Chief Financial Officer Resignation
August 3, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Keith Ruck has resigned as chief financial officer to pursue other interests. The company expects to name a successor shortly.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Following Cancelled FDA Meeting, Kezar To Cut Employees, Eyes Strategic Alternatives
October 17, 2025
·
73 min read
·
BioSpace Editorial Staff
Drug pricing
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic
October 17, 2025
·
3 min read
·
Annalee Armstrong
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
October 17, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
October 17, 2025
·
2 min read
·
Tristan Manalac